IRCT20210614051576N1已完成1 期
Cell therapy using human placenta-derived mesenchymal stem cells(PLMSCs) in patients with Secondary progressive-MS(SPMS): clinical trial phase I
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 17 years 至 45 years（—）
- 性别
- All
入选标准
- •patients with SPMS
- •Age between18–45 years
- •Disease duration of 2 - 16 years
- •Patients who are taking Rituximab drugs
排除标准
- •Pregnant patients
- •Patients with positive results from screening tests (HBV, HCV, HIV, HTLV)
- •Patients with other systemic problems.
研究者
相似试验
招募中
1 期
Infusion of human-derived placental-derived mesenchymal stem cells in patients with acute liver failureIRCT20190717044241N1Tehran University of Medical Sciences5
招募中
1 期
Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical TrialAcute Respiratory Distress Syndrome of COVID-19.COVID-19U07.1IRCT20200413047063N1Execution of Imam Khomeini's Order20
招募中
1 期
The effects of mesenchymal stem cells in COVID-19IRCT20200621047859N4Modiriat Atiye Bahman Company20
进行中（未招募）
不适用
se of mesenchymal cells for the treatment of patients with respiratory syndrome caused by new coronavirusRBR-3fz9yrPaulo Roberto Slud Brofman
招募中
1 期
Cell therapy with use of mesenchymal stem cells in infertile women with Thin EndometriumIRCT20230222057500N1Tehran University of Medical Sciences10